Anacetrapib as Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolaemia (REALIZE): A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study

Journal of Vascular Surgery ◽

10.1016/j.jvs.2016.02.008 ◽

2016 ◽

Vol 63 (4) ◽

pp. 1127-1128

Author(s):

J.J. Kastelein ◽

J. Besseling ◽

S. Shah

Keyword(s):

Familial Hypercholesterolaemia ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Heterozygous Familial Hypercholesterolaemia

Download Full-text

Anacetrapib as lipid-modifying therapy in patients with heterozygous familial hypercholesterolaemia (REALIZE): a randomised, double-blind, placebo-controlled, phase 3 study

10.1016/s0140-6736(14)62115-2 ◽

2015 ◽

Vol 385 (9983) ◽

pp. 2153-2161 ◽

Author(s):

John J P Kastelein ◽

Joost Besseling ◽

Sukrut Shah ◽

Jean Bergeron ◽

Gisle Langslet ◽

...

Keyword(s):

Familial Hypercholesterolaemia ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Heterozygous Familial Hypercholesterolaemia

Download Full-text

Eprotirome in patients with familial hypercholesterolaemia (the AKKA trial): a randomised, double-blind, placebo-controlled phase 3 study

The Lancet Diabetes & Endocrinology ◽

10.1016/s2213-8587(14)70006-3 ◽

2014 ◽

Vol 2 (6) ◽

pp. 455-463 ◽

Author(s):

Barbara Sjouke ◽

Gisle Langslet ◽

Richard Ceska ◽

Stephen J Nicholls ◽

Steven E Nissen ◽

...

Keyword(s):

Familial Hypercholesterolaemia ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Double-blind, placebo-controlled, cross-over trial of probucol in heterozygous familial hypercholesterolaemia

Atherosclerosis ◽

10.1016/0021-9150(85)90097-8 ◽

1985 ◽

Vol 55 (2) ◽

pp. 187-194 ◽

Author(s):

P.N. Durrington ◽

J.P. Miller

Keyword(s):

Familial Hypercholesterolaemia ◽

Double Blind ◽

Double Blind Placebo ◽

Heterozygous Familial Hypercholesterolaemia

Download Full-text

PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial

10.1016/s0140-6736(14)61399-4 ◽

2015 ◽

Vol 385 (9965) ◽

pp. 331-340 ◽

Author(s):

Frederick J Raal ◽

Evan A Stein ◽

Robert Dufour ◽

Traci Turner ◽

Fernando Civeira ◽

...

Keyword(s):

Familial Hypercholesterolaemia ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Pcsk9 Inhibition ◽

Heterozygous Familial Hypercholesterolaemia

Download Full-text

IP 1184. ZX008 (Fenfluramine) in Dravet’s Syndrome: First Results of a Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial

10.1055/s-0038-1676032 ◽

2018 ◽

Author(s):

Tilman Polster ◽

Lieven Lagae ◽

Joseph Sullivan ◽

Ulrich Brandl ◽

Arne Herting ◽

...

Keyword(s):

Controlled Trial ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text

Analysis of adverse events in adult patients with acromegaly receiving oral octreotide capsules: Results from the phase 3, randomized, double-blind, placebo-controlled optimal study

Endocrine Abstracts ◽

10.1530/endoabs.70.aep613 ◽

2020 ◽

Author(s):

Artak Labadzhyan ◽

Susan Samson ◽

Lisa Nachtigall ◽

Maria Fleseriu ◽

Mark E Molitch ◽

...

Keyword(s):

Adverse Events ◽

Adult Patients ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Withdrawal from long-acting somatostatin receptor ligand injections in adult patients with acromegaly: Results from the phase 3, randomized, double-blind, placebo-controlled optimal study

Endocrine Abstracts ◽

10.1530/endoabs.70.aep668 ◽

2020 ◽

Author(s):

Lisa Nachtigall ◽

Susan Samson ◽

Maria Fleseriu ◽

Marek Bolanowski ◽

Molitch Mark E ◽

...

Keyword(s):

Somatostatin Receptor ◽

Adult Patients ◽

Phase 3 ◽

Double Blind ◽

Receptor Ligand ◽

Double Blind Placebo ◽

Long Acting ◽

Somatostatin Receptor Ligand

Download Full-text

Faculty Opinions recommendation of Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13198963.14726480 ◽

2011 ◽

Author(s):

Luciana Mascia ◽

Ilaria Mastromauro

Keyword(s):

Subarachnoid Haemorrhage ◽

Receptor Antagonist ◽

Endothelin Receptor Antagonist ◽

Aneurysmal Subarachnoid Haemorrhage ◽

Endothelin Receptor ◽

Surgical Clipping ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718020575.793481147 ◽

2013 ◽

Author(s):

J Michael Kilby

Keyword(s):

Hiv Infection ◽

Injecting Drug Users ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Antiretroviral Prophylaxis

Download Full-text

Faculty Opinions recommendation of Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718020575.793481120 ◽

2013 ◽

Author(s):

Eric Daar

Keyword(s):

Hiv Infection ◽

Injecting Drug Users ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Antiretroviral Prophylaxis

Download Full-text